| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ... Nature medicine 10 (9), 942-949, 2004 | 6422 | 2004 |
| Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity TJ Curiel, S Wei, H Dong, X Alvarez, P Cheng, P Mottram, R Krzysiek, ... Nature medicine 9 (5), 562-567, 2003 | 1582 | 2003 |
| Tumor antigen-specific T helper cells in cancer immunity and immunotherapy KL Knutson, ML Disis Cancer Immunology, Immunotherapy 54, 721-728, 2005 | 866 | 2005 |
| Next generation of immune checkpoint therapy in cancer: new developments and challenges JA Marin-Acevedo, B Dholaria, AE Soyano, KL Knutson, S Chumsri, ... Journal of hematology & oncology 11, 1-20, 2018 | 822 | 2018 |
| Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide–based vaccines ML Disis, TA Gooley, K Rinn, D Davis, M Piepkorn, MA Cheever, ... Journal of Clinical Oncology 20 (11), 2624-2632, 2002 | 568 | 2002 |
| Folate receptor alpha as a tumor target in epithelial ovarian cancer KR Kalli, AL Oberg, GL Keeney, TJH Christianson, PS Low, KL Knutson, ... Gynecologic oncology 108 (3), 619-626, 2008 | 554 | 2008 |
| Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients KL Knutson, K Schiffman, ML Disis The Journal of clinical investigation 107 (4), 477-484, 2001 | 549 | 2001 |
| Tumor-infiltrating dendritic cells in cancer pathogenesis JM Tran Janco, P Lamichhane, L Karyampudi, KL Knutson The Journal of Immunology 194 (7), 2985-2991, 2015 | 514 | 2015 |
| Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells M Santisteban, JM Reiman, MK Asiedu, MD Behrens, A Nassar, KR Kalli, ... Cancer research 69 (7), 2887-2895, 2009 | 499 | 2009 |
| Rheumatoid arthritis and cardiovascular disease CS Crowson, KP Liao, JM Davis III, DH Solomon, EL Matteson, ... American heart journal 166 (4), 622-628. e1, 2013 | 431 | 2013 |
| The microbiome of aseptically collected human breast tissue in benign and malignant disease TJ Hieken, J Chen, TL Hoskin, M Walther-Antonio, S Johnson, S Ramaker, ... Scientific reports 6 (1), 30751, 2016 | 405 | 2016 |
| Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma FA Sinicrope, RL Rego, SM Ansell, KL Knutson, NR Foster, DJ Sargent Gastroenterology 137 (4), 1270-1279, 2009 | 380 | 2009 |
| TGFβ/TNFα-mediated epithelial–mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype MK Asiedu, JN Ingle, MD Behrens, DC Radisky, KL Knutson Cancer research 71 (13), 4707-4719, 2011 | 338 | 2011 |
| AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells MK Asiedu, FD Beauchamp-Perez, JN Ingle, MD Behrens, DC Radisky, ... Oncogene 33 (10), 1316-1324, 2014 | 314 | 2014 |
| Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369–377, results in short-lived peptide-specific immunity KL Knutson, K Schiffman, MA Cheever, ML Disis Clinical Cancer Research 8 (5), 1014-1018, 2002 | 299 | 2002 |
| Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer J Krempski, L Karyampudi, MD Behrens, CL Erskine, L Hartmann, H Dong, ... The Journal of Immunology 186 (12), 6905-6913, 2011 | 285 | 2011 |
| The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer CC Preston, MJ Maurer, AL Oberg, DW Visscher, KR Kalli, LC Hartmann, ... PloS one 8 (11), e80063, 2013 | 280 | 2013 |
| Tumor immunoediting and immunosculpting pathways to cancer progression JM Reiman, M Kmieciak, MH Manjili, KL Knutson Seminars in cancer biology 17 (4), 275-287, 2007 | 274 | 2007 |
| Augmented HER-2–specific immunity during treatment with trastuzumab and chemotherapy C Taylor, D Hershman, N Shah, N Suciu-Foca, DP Petrylak, R Taub, ... Clinical Cancer Research 13 (17), 5133-5143, 2007 | 253 | 2007 |
| Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma SA Siddiqui, X Frigola, S Bonne-Annee, M Mercader, SM Kuntz, ... Clinical cancer research 13 (7), 2075-2081, 2007 | 251 | 2007 |
